UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 77

of '成人癌症患者静脉血栓栓塞症的风险及预防'

77
TI
Gemcitabine with or without prophylactic weight-adjusted dalteparin (WAD) in patients with advanced or metastatic pancreatic cancer (APC): a multicentre, randomised phase IIB trial (the UK FRAGEM study). Available at www.ncri.org.uk/ncriconference/2009abstracts/abstracts/LB112.htm. Accessed July 20, 2011
AU
Maraveyas A, Waters J, Roy R, et al
SO
Abstract only.
 
AD